PAR
Click for more information
4.17% 25.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-58

  1. TheAnalyst007
    15,441 Posts.
    lightbulb Created with Sketch. 3912
    clock Created with Sketch.
    18/10/23
    11:17
    Post #: 70402144
    I'm sensing we are on the way back up now. Two Cerys trying announcements, the market can't continue to undervalue this solely because the market isn't in a very happy mood at the moment
    PAR Price at posting: 72.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢ 		Change
0.010(4.17%) 		Mkt cap ! $87.44M
Open High Low Value Volume
24.5¢ 25.5¢ 24.5¢ $135.8K 543.6K

Buyers (Bids)

No. Vol. Price($)
1 3000 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 64168 7
View Market Depth
Last trade - 13.25pm 27/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.